Although it is clear that cigarette abuse is closely linked to sexual dysfunction, it is still unclear which are the psychobiological correlates of smoking among individuals with sexual dysfunction. The aim of the present study is the assessment of the organic, psychogenic and relational correlates of erectile dysfunction (ED) in outpatients with different smoking habits. We studied the psychobiological correlates of smoking behaviour in a consecutive series of 1150 male patients, seeking medical care for ED. All patients were investigated using a Structured Interview (SIEDY©), which explores the organic, relational and intra-psychic components of ED, and a self-administered questionnaire for general psychopathology (MHQ). In addition, several biochemical and instrumental parameters were studied, to clarify the biological components underlying ED. Current smokers (CS) showed a higher activation of the hypothalamus–pituitary–testis axis (higher LH, testosterone and right testicular volume) and lower levels of both prolactin and TSH. Hormonal changes were reverted after smoking cessation. CS showed a higher degree of somatized anxiety and were more often unsatisfied of their occupational and domestic lifestyle. Smoking, as part of a risky behaviour, was significantly associated with abuse of alcohol and cannabis. Both CS and past smokers (PS) showed an impairment of subjective and objective (dynamic peak systolic velocity at penile duplex ultrasound) erectile parameters. This might be due to a direct atherogenic effect of smoking, a cigarette-induced alteration of lipid profile (higher triglyceride and lower HDL cholesterol in CS than in non-smokers or PS), or due to a higher use of medications potentially interfering with sexual function. This is the first comprehensive evaluation of the biological and intrapsychic correlates to the smoking habit. Our report demonstrates that smoking has a strong negative impact on male sexual life, even if it is associated at an apparently more sexual-favourable hormonal milieu.
This is a preview of subscription content, access via your institution
Subscribe to Journal
Get full journal access for 1 year
only $14.88 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Akkus E et al. Turkish Erectile Dysfunction Prevalence Study Group. Prevalence and correlates of erectile dysfunction in Turkey: a population-based study. Eur Urol 2002; 41: 298–304.
Blanker MH et al. Erectile and ejaculatory dysfunction in a community-based sample of men 50 to 78 years old: prevalence, concern, and relation to sexual activity. Urology 2001; 57: 763–768.
Bortolotti A, Parazzini F, Colli E, Landoni M . The epidemiology of erectile dysfunction and its risk factors. Int J Androl 1997; 20: 323–334.
Bosch JLHR et al. Erectile dysfunction in a community-based sample of men age 50–75 years: prevalence and somatic and social risk factors. Eur Urol 1999; 35(Suppl 2): 66.
Braun M et al. Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int J Impot Res 2000; 12: 305–311.
Feldman HA et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.
Green JS et al. An investigation of erectile dysfunction in Gwent, Wales. Br J Urol 2001; 88: 551–553.
Kongkanand A . Prevalence of erectile dysfunction in Thailand. Thai Erectile Dysfunction Epidemiological Study Group. Int J Androl 2000; 23: 77–80.
Martin-Morales A et al. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol 2001; 166: 569–575.
McVary KT, Carrier S, Wessells H, Subcommittee on Smoking and Erectile Dysfunction Socioeconomic Committee. Sexual Medicine Society of North America Smoking and erectile dysfunction: evidence based analysis. J Urol 2001; 166: 1624–1632.
Shiri R et al. Effects of age, comorbidity and lifestyle factors on erectile function: Tampere Ageing Male Urological Study (TAMUS). Eur Urol 2004; 45: 628–633.
Nicolosi A, Glasser DB, Moreira ED, Villa M . Erectile Dysfunction Epidemiology Cross National Study Group. Prevalence of erectile dysfunction and associated factors among men without concomitant diseases: a population study. Int J Impot Res 2003; 15: 253–257.
Panser LA et al. Sexual function of men ages 40 to 79 years: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. J Am Geriatr Soc 1995; 43: 1107–1111.
Perttula E . Physician attitude and behaviour regarding erectile dysfunction in at risk patients from a rural community. Postgrad Med J 1999; 75: 83–85.
Schover LR . Sexual Problems and Chronic Disease: A Comprehensive Approach. Guildford Press: New York, 1988.
Tengs TO, Osgood ND . The link between smoking and impotence: two decades of evidence. Prev Med 2001; 32: 447–452.
Ventegodt S . Sex and the quality of life in Denmark. Arch Sex Behav 1998; 27: 295–307.
Parazzini F et al. Frequency and determinants of erectile dysfunction in Italy. Eur Urol 2000; 37: 43–49.
Mirone V et al. Cigarette smoking as risk factor for erectile dysfunction: results from an Italian epidemiological study. Eur Urol 2002; 41: 294–297.
Mirone V et al. Determinants of erectile dysfunction risk in a large series of Italian men attending andrology clinics. Eur Urol 2004; 45: 87–91.
Fung MM, Bettencourt R, Barrett-Connor E . Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo Study. J Am Coll Cardiol 2004; 43: 1405–1411.
Mannino DM, Klevens RM, Flanders WD . Cigarette smoking: an independent risk factor for impotence? Am J Epidemiol 1994; 140: 1003–1008.
Feldman HA et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med 2000; 30: 328–338.
Shiri R et al. Relationship between smoking and erectile dysfunction. Int J Impot Res 2005; 17: 164–169.
Petrone L et al. Structured interview on erectile dysfunction (SIEDY©): a new, multidimensional instrument for quantification of pathogenetic issues on erectile dysfunction. Int J Impot Res 2003; 15: 210–220.
Broderick GA, Foremann MM . Iatrogenic erectile dysfunction: pharmacological and surgical therapies that alter male sexual behaviour and erectile performance. In: Carson C, Kirby R, Goldstein I (eds). Textbook of Erectile Dysfunction. Isis Medical Media Ltd: Oxford, 1999, pp 149–168.
Crown S, Crisp AH . A short clinical diagnostic self-rating scale for psychoneurotic patients. The Middlesex Hospital Questionnaire (M.H.Q.). Br J Psychiatry 1966; 112: 917–923.
Forti G, Krausz C, Cilotti A, Maggi M . Varicocele and infertility. J Endocrinol Invest 2003; 26: 564–569.
Mancini M et al. Duplex ultrasound evaluation of cavernosal peak systolic velocity and waveform acceleration in the penile flaccid state: clinical significance in the assessment of the arterial supply in patients with erectile dysfunction. Int J Androl 2000; 23: 199–204.
Mendelson JH et al. Effects of intravenous cocaine and cigarette smoking on luteinizing hormone, testosterone, and prolactin in men. J Pharmacol Exp Ther 2003; 307: 339–348.
Krsmanovic LZ et al. Muscarinic regulation of intracellular signaling and neurosecretion in gonadotropin-releasing hormone neurons. Endocrinology 1998; 139: 4037–4043.
Trummer H, Habermann H, Haas J, Pummer K . The impact of cigarette smoking on human semen parameters and hormones. Hum Reprod 2002; 17: 1554–1559.
Deslypere JP, Vermeulen A . Leydig cell function in normal men: effect of age, life-style, residence, diet, and activity. J Clin Endocrinol Metab 1984; 59: 955–962.
Ary DV, Lichtenstein E, Severson HH . Smokeless tobacco use among male adolescents: patterns, correlates, predictors, and the use of other drugs. Prev Med 1987; 16: 385–401.
Dai WS, Gutai JP, Kuller LH, Cauley JA . Cigarette smoking and serum sex hormones in men. Am J Epidemiol 1988; 128: 796–805.
Field AE et al. The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men. J Clin Endocrinol Metab 1994; 79: 1310–1316.
Voors AA et al. Smoking and cardiac events after venous coronary bypass surgery. A 15-year follow-up study. Circulation 1996; 93: 42–47.
Muller M et al. Endogenous sex hormones in men aged 40–80 years. Eur J Endocrinol 2003; 149: 583–589.
Svartberg J et al. The associations of age, lifestyle factors and chronic disease with testosterone in men: the TromsÃ, Study. Eur J Endocrinol 2003; 149: 145–152.
Laaksonen DE et al. The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study. J Clin Endocrinol Metab 2005; 90: 712–719.
Couillard C et al. Contribution of body fatness and adipose tissue distribution to the age variation in plasma steroid hormone concentrations in men: the HERITAGE Family Study. J Clin Endocrinol Metab 2000; 85: 1026–1031.
Harman SM et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 2001; 86: 724–731.
Corona G et al. Aging and pathogenesis of erectile dysfunction. Int J Impot Res 2004; 16: 395–402.
Bauman KE, Foshee VA, Haley NJ . The interaction of sociological and biological factors in adolescent cigarette smoking. Addict Behav 1992; 17: 459–467.
James WH . Hypothesis: gonadal hormones act as confounders in epidemiological studies of the association between some behavioural risk factors and some pathological conditions. J Theor Biol 2001; 209: 97–102.
Martin JF . Tobacco smoking as a form of child abuse. Eur J Public Health 2002; 12: 236–237.
Powell JH et al. Cognitive and psychological correlates of smoking abstinence, and predictors of successful cessation. Addict Behav 2004; 29: 1407–1426.
Dinn WM, Aycicegi A, Harris CL . Cigarette smoking in a student sample: neurocognitive and clinical correlates. Addict Behav 2004; 29: 107–126.
Tselebis A et al. Smoking related to anxiety and depression in Greek medical staff. Psychol Rep 2003; 92: 529–532.
McCabe RE et al. Smoking behaviors across anxiety disorders. J Anxiety Disord 2004; 18: 7–18.
Isensee B et al. Smoking increases the risk of panic: findings from a prospective community study. Arch Gen Psychiatry 2003; 60: 692–700.
John U, Meyer C, Rumpf HJ, Hapke U . Smoking, nicotine dependence and psychiatric comorbidity—a population-based study including smoking cessation after three years. Drug Alcohol Depend 2004; 76: 287–295.
Khazaal Y, Cornuz J, Zullino D . Are anxiety disorders associated to a particular addiction to smoking? Stress, anxiety and nicotine addiction. Sante Ment Que 2004; 29: 73–80.
Weigert M et al. The effect of smoking on oocyte quality and hormonal parameters of patients undergoing in vitro fertilization-embryo transfer. J Assist Reprod Genet 1999; 16: 287–293.
Fisher CL, Mannino DM, Herman WH, Frumkin H . Cigarette smoking and thyroid hormone levels in males. Int J Epidemiol 1997; 26: 972–977.
Knudsen N et al. High occurrence of thyroid multinodularity and low occurrence of subclinical hypothyroidism among tobacco smokers in a large population study. J Endocrinol 2002; 175: 571–576.
Belin RM, Astor BC, Powe NR, Ladenson PW . Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third national health and nutrition examination survey (NHANES III). J Clin Endocrinol Metab 2004; 89: 6077–6086.
Fuxe K et al. Neuroendocrine actions of nicotine and of exposure to cigarette smoke: medical implications. Psychoneuroendocrinology 1989; 14: 19–41.
Ambrose JA, Barua RS . The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 2004; 19: 1731–1737.
Landmesser U, Hornig B, Drexler H . Endothelial function: a critical determinant in atherosclerosis? Circulation 2004; 109(Suppl 1): 1127–1133.
Craig WY, Palomaki GE, Haddow JE . Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. Br Med J 1989; 298: 784–788.
Heitzer T et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 1996; 93: 1346–1353.
Kharb S, Singh GP . Effect of smoking on lipid profile, lipid peroxidation and antioxidant status in normal subjects and in patients during and after acute myocardial infarction. Clin Chim Acta 2000; 302: 213–219.
Lopes PA, Santos MC, Vicente L, Viegas-Crespo AM . Effect of cigarette smoking on serum alpha-tocopherol and the lipid profile in a Portuguese population. Clin Chim Acta 2004; 348: 49–55.
Elhanbly S et al. Erectile dysfunction in smokers: a penile dynamic and vascular study. J Androl 2004; 25: 991–995.
About this article
Cite this article
Corona, G., Mannucci, E., Petrone, L. et al. Psychobiological correlates of smoking in patients with erectile dysfunction. Int J Impot Res 17, 527–534 (2005). https://doi.org/10.1038/sj.ijir.3901351
- erectile dysfunction
- smoking testosterone
- structured interview
This article is cited by
People smoke for nicotine, but lose sexual and reproductive health for tar: a narrative review on the effect of cigarette smoking on male sexuality and reproduction
Journal of Endocrinological Investigation (2020)
Nature Reviews Disease Primers (2016)
International Journal of Impotence Research (2006)